Back to Companies
Inhibitor Therapeutics, Inc.
INTIOTCCIK: 0001042418
Over the 6 most recent insider filings, Inhibitor Therapeutics, Inc. (INTI) has seen activity from 6 distinct insiders — no open-market buying or selling. Black Robe Capital LLC (10% Owner) is the most active by dollar volume. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$0
Purchases
$0
Sales
$0
Unique Insiders
6
Recent Insider Trades
6 loaded
| Aug 4 | INTI Inhibitor Therapeutics, Inc. | Black Robe Capital LLC | 10% Owner | Gift | $0 |
| Aug 4 | INTI Inhibitor Therapeutics, Inc. | ODONNELL FRANCIS E JR | Chief Executive Officer, Director, 10% Owner | Grant | $0 |
| Aug 4 | INTI Inhibitor Therapeutics, Inc. | OSMAN RONALD E | Director, 10% Owner | Grant | $0 |
| Aug 4 | INTI Inhibitor Therapeutics, Inc. | Yanez Michelle | Director | Grant | $0 |
| Jun 24 | INTI Inhibitor Therapeutics, Inc. | Jerman Michael Allen | Director | Grant | $0 |
| Aug 4 | INTI Inhibitor Therapeutics, Inc. | SEARS SAMUEL P JR | Director | Grant | $0 |
6 filings